-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target

Benzinga·10/29/2025 12:43:48
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.